Top

Quality of Life Research

Gepubliceerd in:

18-04-2018

Measurement properties of ThyPRO short-form (ThyPRO-39) for use in Chinese patients with benign thyroid diseases

Auteurs: Carlos K. H. Wong, Edmond P. H. Choi, Y. C. Woo, Brian H. H. Lang

Gepubliceerd in: Quality of Life Research | Uitgave 8/2018

Abstract

Purpose

To evaluate the validity and reliability of a newly-translated Thyroid-specific Patient-Reported Outcome short-form (ThyPRO-39) instrument for ethnic-Chinese patients suffering from benign thyroid diseases.

Methods

The translation and cross-cultural adaptation of the English ThyPRO-39 were performed using the double forward translation, reconciliation, single backward translation, and cognitive debriefing, followed by a panel review. Cross-sectional data of 308 patients with benign thyroid diseases were utilized for this psychometric evaluation of ThyPRO-39 instrument. Convergent validity between similar construct in the ThyPRO-39, SF-6D, and SF-12v2 was assessed using Spearman correlations. The internal construct validity was assessed by corrected item-total correlations. Sensitivity of the ThyPRO-39 domain scores was determined by performing known group comparisons by independent t test. The internal consistency reliability was assessed by Cronbach’s alpha coefficient.

Results

Significant floor effects were observed in 9 out of 13 domains of the ThyPRO-39. The hypothesized correlations between similar constructs in the ThyPRO-39 and the SF-12v2 and SF-6D were generally observed, supporting convergent validity. The internal construct validity was supported in most items, except eight items in six scales. Scale score of hyperthyroid symptoms of the ThyPRO-39 was significantly higher in the group with Graves’ disease or hyperthyroid disease than the group without Graves’ disease nor hyperthyroid disease. Scale scores of eye symptoms and impaired daily life were significantly higher in the incidental group than the non-incidental group. For six domains (hyperthyroid symptoms, hypothyroid symptoms, eye symptoms, tiredness, depressivity, and emotional susceptibility), Cronbach’s alpha did not reach the recommended standard of 0.7.

Conclusions

This was the first psychometric study to translate and adapt the ThyPRO-39 instrument for non-Caucasian patients, and report its validity and reliability for use in Chinese patients with benign thyroid diseases. Given the low item-total correlations in eight items and low internal consistency reliability in respective scales of the ThyPRO-39, we suggest that the improvement of those eight items should produce a more valid and reliable ThyPRO-39 instrument.

vorige artikel Giving voice to the child perspective: psychometrics and relative precision findings for the Child Health Questionnaire self-report short form (CHQ-CF45)

volgende artikel Measuring quality of life in patients with stress urinary incontinence: is the ICIQ-UI-SF adequate?

Garmendia Madariaga, A., Santos Palacios, S., Guillén-Grima, F., & Galofré, J. C. (2014). The incidence and prevalence of thyroid dysfunction in Europe: A meta-analysis. The Journal of Clinical Endocrinology & Metabolism, 99(3), 923–931.CrossRef

Wang, J., Ma, X., Qu, S., Li, Y., Han, L., Sun, X., et al. (2013). High prevalence of subclinical thyroid dysfunction and the relationship between thyrotropin levels and cardiovascular risk factors in residents of the coastal area of China. Experimental & Clinical Cardiology, 18(1), e16.

Morris, L. G., Sikora, A. G., Tosteson, T. D., & Davies, L. (2013). The increasing incidence of thyroid cancer: The influence of access to care. Thyroid, 23(7), 885–891.CrossRefPubMedPubMedCentral

Leese, G., Flynn, R., Jung, R., Macdonald, T., Murphy, M., & Morris, A. (2008). Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: The Thyroid Epidemiology Audit and Research Study (TEARS). Clinical Endocrinology (Oxford), 68(2), 311–316.

Lang, B. H., Wong, C. K., & Chan, C. T. (2015). Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: A health care service provider perspective. European Journal of Surgical Oncology (EJSO), 41(6), 758–765.CrossRef

Watt, T., Groenvold, M., Rasmussen, ÅK., Bonnema, S. J., Hegedüs, L., Bjorner, J. B., et al. (2006). Quality of life in patients with benign thyroid disorders. A review. European Journal of Endocrinology, 154(4), 501–510.CrossRefPubMed

Links, T., Van Tol, K., Jager, P., Plukker, J. T. M., Piers, D., Boezen, H., et al. (2005). Life expectancy in differentiated thyroid cancer: A novel approach to survival analysis. Endocrine-Related Cancer, 12(2), 273–280.CrossRefPubMed

Schlumberger, M. J. (1998). Papillary and follicular thyroid carcinoma. New England Journal of Medicine, 338(5), 297–306.CrossRefPubMed

Sherma, S. I. (2003). Thyroid carcinoma. The Lancet, 361(9356), 501–511.CrossRef

10.

Büttner, M., Musholt, T. J., & Singer, S. (2017). Quality of life in patients with hypoparathyroidism receiving standard treatment: A systematic review. Endocrine, 58(1), 14–20.CrossRefPubMed

11.

Husson, O., Haak, H. R., Oranje, W. A., Mols, F., Reemst, P. H., & van de Poll-Franse, L. V. (2011). Health-related quality of life among thyroid cancer survivors: A systematic review. Clinical Endocrinology (Oxford), 75(4), 544–554.CrossRef

12.

Elberling, T., Rasmussen, A., Feldt-Rasmussen, U., Hording, M., Perrild, H., & Waldemar, G. (2004). Impaired health-related quality of life in Graves’ disease. A prospective study. European Journal of Endocrinology, 151(5), 549–555.CrossRefPubMed

13.

Wong, C. K., Lang, B. H., & Lam, C. L. (2016). A systematic review of quality of thyroid-specific health-related quality-of-life instruments recommends ThyPRO for patients with benign thyroid diseases. Journal of Clinical Epidemiology, 78, 63–72.CrossRefPubMed

14.

Watt, T., Rasmussen, ÅK., Groenvold, M., Bjorner, J. B., Watt, S. H., Bonnema, S. J., et al. (2008). Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing. Quality of Life Research, 17(7), 1009.CrossRefPubMed

15.

Watt, T., Bjorner, J. B., Groenvold, M., Rasmussen, ÅK., Bonnema, S. J., Hegedüs, L., et al. (2009). Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): An initial examination. Quality of Life Research, 18(4), 483–496.CrossRefPubMed

16.

Watt, T., Hegedüs, L., Groenvold, M., Bjorner, J. B., Rasmussen, ÅK., Bonnema, S. J., et al. (2010). Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. European Journal of Endocrinology, 162(1), 161–167.CrossRefPubMed

17.

Watt, T., Barbesino, G., Bjorner, J. B., Bonnema, S. J., Bukvic, B., Drummond, R., et al. (2015). Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO. Quality of Life Research, 24(3), 769–780.CrossRefPubMed

18.

Watt, T., Bjorner, J. B., Groenvold, M., Cramon, P., Winther, K. H., Hegedüs, L., et al. (2015). Development of a short version of the thyroid-related patient-reported outcome ThyPRO. Thyroid, 25(10), 1069–1079.CrossRefPubMed

19.

Sawicka-Gutaj, N., Watt, T., Sowinski, J., Gutaj, P., Waligorska-Stachura, J., & Ruchala, M. (2015). ThyPROpl-The Polish version of the thyroid-specific quality of life questionnaire ThyPRO. Endokrynologia Polska, 66(4), 367–380.CrossRefPubMed

20.

Gerenova, J., Watt, T., & Dimanova, B. D. (2017). ThyPRO-39bg: Translation and validation in Bulgarian of thyroid-specific quality of life questionnaire ThyPRO-39. Endocrinologia, 22(1), 12–20.

21.

Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., et al. (2005). Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR task force for translation and cultural adaptation. Value in Health, 8(2), 94–104.CrossRefPubMed

22.

Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., et al. (2016). 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26(1), 1–133.CrossRefPubMedPubMedCentral

23.

Lam, E. T., Lam, C. L., Fong, D. Y., & Huang, W. W. (2013). Is the SF-12 version 2 health survey a valid and equivalent substitute for the SF-36 version 2 health survey for the Chinese? Journal of Evaluation in Clinical Practice, 19(1), 200–208.CrossRefPubMed

24.

Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851–859.CrossRefPubMed

25.

Lam, C. L., Brazier, J., & McGhee, S. M. (2008). Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value in Health, 11(2), 295–303.CrossRefPubMed

26.

McGhee, S. M., Brazier, J., Lam, C., Wong, L., Chau, J., Cheung, A., et al. (2011). Quality-adjusted life years: Population-specific measurement of the quality component. Hong Kong Medical Journal, 17(Suppl 6), 17–21.PubMed

27.

Wong, C. K. H., Lang, B. H. H., Yu, H. M. S., & Lam, C. L. K. (2017). EQ-5D-5L and SF-6D utility measures in symptomatic benign thyroid nodules: Acceptability and psychometric evaluation. The Patient, 10(4), 447–454.CrossRefPubMed

28.

Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.CrossRefPubMed

29.

Ware, J. E., & Gandek, B. (1998). Methods for testing data quality, scaling assumptions, and reliability: The IQOLA project approach. Journal of Clinical Epidemiology, 51(11), 945–952.CrossRefPubMed

30.

Nunnally, J. C. (1978). Psychometric theory. New York: McGraw-Hill.

31.

Bowling, A. (2005). Mode of questionnaire administration can have serious effects on data quality. Journal of Public Health-UK, 27(3), 281–291.CrossRef

32.

Lewis-Beck, M., Bryman, A. E., & Liao, T. F. (2003). The SAGE encyclopedia of social science research methods. Thousand Oaks: SAGE.

33.

Patrick, D. L., & Deyo, R. A. (1989). Generic and disease-specific measures in assessing health status and quality of life. Medical Care, 27, S217–S32.CrossRefPubMed

34.

Bianchi, G. P., Zaccheroni, V., Solaroli, E., Vescini, F., Cerutti, R., Zoli, M., et al. (2004). Health-related quality of life in patients with thyroid disorders. Quality of Life Research, 13(1), 45–54.CrossRefPubMed

Titel: Measurement properties of ThyPRO short-form (ThyPRO-39) for use in Chinese patients with benign thyroid diseases
Auteurs: Carlos K. H. Wong
Edmond P. H. Choi
Y. C. Woo
Brian H. H. Lang
Publicatiedatum: 18-04-2018
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 8/2018
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-018-1857-9

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 8/2018

Quality of life in older adults with sensory impairments: a systematic review

A systematic review of Indigenous caregiver functioning and interventions

Prevalence of context effects: testing with a straightforward question of yesterday happiness

A new algorithm to build bridges between two patient-reported health outcome instruments: the MOS SF-36® and the VR-12 Health Survey

Influence of sense of coherence on oral health-related quality of life: a systematic review

The sensitivity of the MOS SF-12 and PROMIS® global summary scores to adverse health events in an older cohort